FINWIRES · TerminalLIVE
FINWIRES

DocuSign Delivered Strong Fiscal Q2 Results, Continued IAM Platform Strength, RBC Says

By

DocuSign (DOCU) delivered strong fiscal Q2 results that exceeded consensus across all metrics, along with continued momentum for its Intelligent Agreement Management, or IAM, platform, RBC Capital Markets said in a note Thursday.

The company raised its fiscal 2027 annual recurring revenue growth guidance to 8.5% to 9.0%, while growing deal sizes were also encouraging, though shares appear fully valued at current levels, the note said.

Underlying organic growth in fiscal Q2 was driven primarily by accelerating IAM adoption and improved retention, while deal sizes continued to increase, with customers having more than $300,000 in annual contract value growing 14% to 1,296, the second consecutive quarter of double-digit growth, RBC added.

For fiscal Q3, the company expects revenue of $886 million to $890 million. Management expects IAM to account for 18% to 19% of ARR in fiscal 2027, the brokerage said.

RBC kept a sector perform rating on DocuSign and raised its price target to $70 from $55.

Price: $67.69, Change: $+1.72, Percent Change: +2.60%

Related Articles

Wire

Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data

Vaxcyte (PCVX) appointed Luis Jodar as chief medical officer and David McAvoy as chief legal officer, the company said on Thursday.Jodar spent 17 years at Pfizer (PFE), most recently as senior vice president and chief medical officer for Vaccines and Infectious Diseases, the company said.McAvoy joins the company from Teva Pharmaceutical (TEVA), according to a statement.The vaccine developer also said it now expects to report topline data from its phase 3 OPUS-1 trial of VAX-31 in adults by the end of October, narrowing its previous guidance of a Q4 data release.

$PCVX
Wire

eGain Fiscal Q4 Adjusted Earnings, Revenue Fall; Shares Slump After Hours

EGain (EGAN) reported fiscal Q4 adjusted earnings late Thursday of $0.08 per diluted share, down from $0.09 a year earlier.Three analysts polled by FactSet projected $0.03.Revenue in the three months ended June 30 fell to $22.2 million from $23.2 million a year earlier.Three analysts projected $21.7 million.The company expects fiscal Q1 adjusted EPS of $0.05 to $0.08 on revenue of $20.9 million to $21.4 million. Three analysts project EPS of $0.08 on revenue of $22.3 million.For fiscal 2027, eGain expects adjusted EPS of $0.04 to $0.07 on revenue of $84.5 million to $86 million. Three analysts project EPS of $0.43 on revenue of $94.1 million.EGain shares slumped 29% in after-hours trading.

$EGAN
Wire

American Outdoor Brands Fiscal Q1 Swings to Adjusted Earnings, Revenue Rises

American Outdoor Brands (AOUT) reported fiscal Q1 non-GAAP earnings late Thursday of $0.03 per diluted share, swinging from a loss $0.26 year earlier.Two analysts polled by FactSet expected a loss of $0.24.Net sales for the quarter ended July 31 were $37.3 million, up from $29.7 million a year earlier.Two analysts expected $35.6 million.For fiscal 2027, the company maintained its net sales forecast of $200 million to $210 million. Two analysts expect $205.1 million.Shares of the company rose over 16% in after-hours trading.

$AOUT